Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition - Wikidata - wikimedia - TriplyDB

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

http://www.wikidata.org/entity/Q37228160

about

Alzheimer's disease as homeostatic responses to age-related myelin breakdown The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data Brain structure and obesity Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 Biological markers of Alzheimer's disease The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception The clinical value of large neuroimaging data sets in Alzheimer's disease The internet brain volume database: a public resource for storage and retrieval of volumetric data The Alzheimer's disease neuroimaging initiative: progress report and future plans Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative Using structural and diffusion magnetic resonance imaging to differentiate the dementias.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data.Using NMR approaches to drive the search for new CNS therapeutics.Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis.Biomarkers in Alzheimer's disease: past, present and future.Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.Targeting Abeta and tau in Alzheimer's disease, an early interim report Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Recent advances in imaging Alzheimer's disease.Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.An MRI-derived definition of MCI-to-AD conversion for long-term, automatic prognosis of MCI patients.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans Role of structural MRI in Alzheimer's disease Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort.

P2860

Q22251261-047375BF-3586-4CA5-B369-28105E93D187 Q24289484-3B1DAF79-CE2C-4D61-BDAB-486B9DBEC8AF Q24644378-E3A56C0C-19C3-4595-BB7F-751143F76AA8 Q26744866-F58C4DF1-9657-4E9F-B2BF-51CA8EC627EF Q26801629-8A2E78B9-53E7-48C6-8041-3880CF9ADBE1 Q26823847-21BDF859-35AB-4EC4-800A-9989948AC569 Q27006831-D857F7BD-DC82-41CB-A247-8A342867B5E4 Q28709465-D066C27D-8400-40AE-BD3E-D9DF902C4D8B Q28728475-CDB77990-B7B6-4FB7-8516-72FD8E9B738E Q28749585-4E7E7079-3E54-4E78-A2FC-43515902BA91 Q30476040-DE1D029C-57E1-4373-BF0F-FC64D5A82809 Q30666527-9FD0B8F3-FB75-42BD-B2AB-943CB77AEAAC Q30724134-A4ED9BCB-5E69-4631-92E2-3F1B7551885D Q30836806-BD249821-D20B-48DF-AC20-D6E8C55B2C2E Q30971403-ACBE6494-3160-42DF-9E1D-924FA4A9729A Q30981669-34FDD292-75B0-476D-B604-55DC8153244D Q33518172-E1B2F6F1-51D7-4E33-9E12-E35FBC8717A4 Q33613767-3F80838B-651F-493D-ADC7-7299943CD14C Q33651118-92134008-2AEF-4AE1-AABE-63D1AE9B04D8 Q33665060-A1E0A23D-7D70-494E-97C0-598BC534437E Q33689474-5DBB8385-CCDC-4539-92C6-0E08C065D04F Q33759240-9FBE4815-2348-4AFC-A01C-676B4A552F6E Q33761696-CD643DB5-A612-4EE4-A72B-3F60FEB61627 Q33791646-F02013BD-A095-4DCE-942F-254F2868E250 Q33794509-B6202F40-A6EC-47C9-B145-F2C6BBB6D3FB Q33829008-D55B7C99-D039-49E5-B316-A32B08D62E49 Q33842486-991B2E77-49D6-4668-B5A9-0D9FBB4AD814 Q33881726-61732F6C-B875-40EC-AEBF-8B3B4E6586F5 Q33946440-5E07E958-6252-43E7-B9FC-E96EF9A41F7B Q33987747-751E0D73-6B20-4D6E-B6F2-FFD1F4D8B75B Q33990243-20CFB36C-D27A-4F41-A909-006E059441CE Q33996059-F8604C91-647C-44DF-9C9D-5F2E2B4E40A3 Q33997421-7DBAABBB-44ED-47D7-AF61-1D0FB9259848 Q34039952-0C3B1726-A280-4122-8C72-58756232754E Q34055510-15735856-B912-4AB6-8F5A-01A3655BE5E4 Q34065449-55145728-AD04-424B-93A5-1737FD41A6FE Q34073224-D25A6A30-5541-49EB-9533-22AFD0F11A96 Q34081087-3E1DF59D-2F82-4988-A8D9-2E233CC4A4EC Q34173192-979E9D47-E67E-49C8-A90A-70DAB7880919 Q34180980-E7315A3B-204F-4617-AA08-6F55A87DA25D

P2860

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

http://www.wikidata.org/entity/Q37228160

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alzheimer's disease neuroimagi ...... ates, biomarkers and cognition

@en

Alzheimer's disease neuroimagi ...... tes, biomarkers and cognition.

@nl

type

label

Alzheimer's disease neuroimagi ...... ates, biomarkers and cognition

@en

Alzheimer's disease neuroimagi ...... tes, biomarkers and cognition.

@nl

prefLabel

Alzheimer's disease neuroimagi ...... ates, biomarkers and cognition

@en

Alzheimer's disease neuroimagi ...... tes, biomarkers and cognition.

@nl

P1433

Q37228160-4D0770C8-DA07-4E6E-AF3D-CA4D411FCCA5

P1476

Q37228160-09A6EABE-EC6C-43D6-B226-333ED6BFABBA

P2093

Q37228160-06BA29F8-0DF2-4E1B-BDEE-9A82962C0BD3

Q37228160-3BC754D1-F5B7-4769-A1AA-5B10507AE99B

Q37228160-3CC65656-2377-4CB4-A866-CA705E469C14

Q37228160-7A230886-9983-4864-B17A-FD2D42665BA1

Q37228160-9EF1C887-C003-4C56-A718-3D4C6B88EEC1

Q37228160-B3B7B144-4A71-4B22-BBF9-33AD11AD1858

Q37228160-C1F4223A-53C4-4BA1-9472-60AF5C5838B1

Q37228160-C3DF0491-E499-4CF8-B04F-34E9B57F2FAB

Q37228160-CCF30AE8-97DB-48B0-936B-C89B4EEBA7AF

Q37228160-D241CD99-E86F-43FC-B15B-23E154FB0553

P2860

Q37228160-002A026D-8941-40B5-A7A7-F5B213CDF0B9

Q37228160-003ADE4D-384E-4D6E-A89B-43F999A84545

Q37228160-04B52D4F-5821-4709-A2DE-22CD397AF766

Q37228160-04FA7A04-4A58-451E-9FF2-F55FB8088A9A

Q37228160-0662B0DB-3FF5-4CF9-9A9F-4B31D49A1765

Q37228160-07310C06-CFFC-4DCC-8B07-3A96D0803392

Q37228160-0A9C6CFF-6EFF-46E9-8A3D-1FBA3816183F

Q37228160-0AFE8374-8161-46B4-B636-D2737DFA43A9

Q37228160-0B3FAC66-4623-455D-B780-DDF5C89A789D

Q37228160-0DCCE0DB-6C3D-4026-924A-993409023E60

P304

Q37228160-E3FF5CD9-832F-49EA-B4FC-2D6B71905F66

P31

Q37228160-2114D2F7-FB0B-4C07-928D-C9D82DD009C9

P356

Q37228160-232416C0-A5C8-4EAA-94A9-0E910A9911FE

P407

Q37228160-C562E30E-4161-4386-B4C1-60BBBE55036C

P433

Q37228160-3A603CFD-C29A-462E-AB33-A3493CC439A1

P478

Q37228160-3AC4E3B0-967B-4456-A833-9791865F7636

P50

Q37228160-00D696C3-D45C-4566-935A-6A7AD9477AB3

Q37228160-22FD7A20-CD6D-4F69-BAFD-88568383917D

Q37228160-2DF951FD-7241-411F-9D7B-7C4544B1D881

Q37228160-2E452741-414A-4491-8237-1137C99B74FB

Q37228160-47BF1692-0787-4385-8E07-5EF124213C5D

Q37228160-8925860F-399B-4BC9-A040-43C3D326DB8A

Q37228160-C0A2A68C-21A0-427D-BD59-EEC3D0B7D905

Q37228160-C46E3D32-AA25-4620-9978-C142B1FE4CAE

Q37228160-F6FC9D04-DB5B-4EE1-98F4-E6EA916ACDB6

P577

Q37228160-AD7242CB-471F-4E10-A60D-9F9CBE85ACDE

P5875

Q37228160-30DA9B2C-C2A0-47FC-9CE8-8B361FFD9E1E

P698

Q37228160-8C1D1C1F-4FAF-4F17-881C-FD35266EE95A

P921

Q37228160-51B79131-A001-423C-9D57-A9ADA60D605A

Q37228160-63A12790-3A8C-4ED0-BB37-D430CC68CD4B

Q37228160-AB23B163-0505-46DC-8193-716F8A1EF6F9

Q37228160-D386B670-2E1C-4E84-9686-0ADB0690688D

P932

Q37228160-B1A9F9B3-1767-4F43-A33F-B9173309D106

P356

J.NEUROIMAGE.2009.01.004

P1433

P1476

Alzheimer's disease neuroimagi ...... ates, biomarkers and cognition

@en

P2093

Adam S Fleisher

http://www.w3.org/2001/XMLSchema#string

Alex D Leow

http://www.w3.org/2001/XMLSchema#string

Bret Borowski

http://www.w3.org/2001/XMLSchema#string

Chadwick P Ward

http://www.w3.org/2001/XMLSchema#string

Danielle Harvey

http://www.w3.org/2001/XMLSchema#string

Gene E Alexander

http://www.w3.org/2001/XMLSchema#string

Igor Yanovsky

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Gunter

http://www.w3.org/2001/XMLSchema#string

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

Neelroop Parikshak

http://www.w3.org/2001/XMLSchema#string

P2860

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Voxel-based morphometry--the methods

Mild cognitive impairment: clinical characterization and outcome

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

Nonparametric permutation tests for functional neuroimaging: a primer with examples

A voxel-based morphometric study of ageing in 465 normal adult human brains

BrainSuite: An automated cortical surface identification tool

P304

645-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROIMAGE.2009.01.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Paul M. Thompson

Alzheimer's Disease Neuroimaging Initiative

Matt A Bernstein

Michael W. Weiner

John Q. Trojanowski

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24441638

http://www.w3.org/2001/XMLSchema#string

P698

19280686

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Alzheimer's Disease Neuroimaging Initiative

P932

2696624

http://www.w3.org/2001/XMLSchema#string